Study Information
| Title: | A Study of E7080 Alone, and in Combination With Everolimus in Subjects With Unresectable Advanced or Metastatic Renal Cell Carcinoma Following One Prior Vascular Endothelial Growth Factor (VEGF)-Targeted Treatment  |
| Status: | Recruiting participants |
| Conditions: | Metastatic Renal Cell Carcinoma |
| Interventions: | Drug: E7080; Drug: Everolimus; Drug: E7080 plus Everolimus |
| Health Topics: | Kidney Cancer |